EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12 Cr | ₹14 Cr | ₹21 Cr | ₹18 Cr | ₹19 Cr |
What is the latest Total Non-Current Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹19 Cr |
How is Total Non-Current Liabilities of EVEREST ORGANICS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | -10.32 | |
| Mar2025 | ₹14 Cr | -34.93 | |
| Mar2024 | ₹21 Cr | 15.12 | |
| Mar2023 | ₹18 Cr | -3.16 | |
| Mar2022 | ₹19 Cr | - | |
Compare Total Non-Current Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹241.3 Cr | 0.9% | 7.2% | -39.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 0.9% |
7.2% |
-39.2% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses